Valley Fever Institute
1700 Mount Vernon Avenue 661.706.6748

Valley Fever Research Study

Adults diagnosed with pneumonia meeting study criteria may inquire about this research study for early treatment for Valley Fever.

This study seeks to treat possible Valley Fever illness before the test results are available. If someone does have Valley Fever pneumonia, early treatment may prevent serious effects on health from the fungus that causes Valley Fever.

You may be eligible for this study if you:

  • Have been diagnosed with community-acquired pneumonia (CAP) within 48 hours.
  • Were treated with an antibiotic and are at least 18 years of age and have a prescription for CAP antibiotic treatment.
  • Contact the study phone number at 661.706.6748 within 48 hours of receiving an antibiotic for your pneumonia.

What is involved?

  • Receiving either the medication for Valley Fever pneumonia or placebo (inactive substance) and initial blood tests, ECG, etc.
  • Follow-up clinic visits, questionnaires and blood draws for up to a 6 month period.
  • For the study care and study visits, participants will be registered as a patient at Kern Medical; study care is at no cost to participants.

Qualifying participants will receive up to $550 to assist with the cost of travel and time.

If you would like more information about this study, please call (661) 706-6748 and a study team member will return your call as soon as possible.